Unique Challenges of Assessing the Value of Treatments for Rare Diseases

In a recent post on the IVI-sponsored Health Affairs featured blog series, IVI's Executive Director, Darius Lakdawalla, and Anupam Jena recommend that creators of value frameworks recognize the unique issues associated with valuing treatments for rare diseases by adopting societal, as well payer-oriented perspectives. Included in this assessment are the important roles of treatment spillovers, societal preferences about health [...]

2017-07-14T07:20:06-04:00April 12th, 2017|Viewpoints|

Network Meta-Analysis Needed to Improve Clinical Oncology Value Framework

In his letter to the editor published in the Journal of Clinical Oncology, IVI's Evidence Synthesis Expert, Jeroen Jansen, argues that network meta-analysis is the only transparent framework to help answer the treatment selection question. Responding to his letter, members of the ASCO Task Force reply that Dr. Jansen makes a "strong argument for the use [...]

2017-07-18T22:07:36-04:00April 1st, 2017|Viewpoints|

Examining Value Frameworks and Key Considerations for Improvement

In a recent post on the IVI-sponsored Health Affairs featured blog series, the National Pharmaceutical Council's Robert Dubois (also member of IVI Strategic Advisory Panel) and Kimberly Westrich examine current value assessment models' readiness for use in healthcare decision-making. Applying NPC's 35 Guiding Practices, they conclude that all existing frameworks possess individual strengths and weaknesses, but [...]

2017-07-14T07:22:53-04:00March 2nd, 2017|Viewpoints|

How New Value Frameworks Can Undermine the Ability of Patients and Providers to Find the Best Treatment

In Tomas Philipson's latest Forbes.com op-ed, he and co-author Jason Shafrin (IVI Director of Research) describe the potential for new value frameworks to undermine the ability of patients and providers to find the best treatment for a specific patient. Read the full article here.

2017-07-14T07:28:07-04:00August 4th, 2016|Viewpoints|
Go to Top